CardioWise’s Cardiac CT Image Analysis Software Cleared by FDA

January 8, 2021

CardioWise has been granted 510(k) marketing clearance for SQuEEZ (Stretch Quantifier for Endocardial Engraved Zones), the company’s imaging analysis software for cardiac computed tomography (CT) studies.

The software, which is designed to help cardiologists and radiologists evaluate heart function in patients with symptoms of heart disease, color codes and highlights motions of the heart wall and it can help to assess the heart’s ability to pump blood through the left ventricle.

Cardiac CT combined with SQuEEZ analysis software “can provide clinicians with a normalized measurement to determine … [if] contractile function [is] normal or not normal,” the company said.

View today's stories